A detailed history of Elequin Capital LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Elequin Capital LP holds 27 shares of JAZZ stock, worth $3,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Holding current value
$3,325
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $2,715 - $3,141
27 New
27 $3,000
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $13,230 - $15,893
108 New
108 $13,000
Q3 2022

Nov 10, 2022

SELL
$126.59 - $161.18 $23,292 - $29,657
-184 Reduced 60.53%
120 $16,000
Q2 2022

Aug 11, 2022

BUY
$141.59 - $168.66 $4,955 - $5,903
35 Added 13.01%
304 $47,000
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $34,873 - $43,228
269 New
269 $42,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.72B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Elequin Capital LP Portfolio

Follow Elequin Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elequin Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Elequin Capital LP with notifications on news.